Margaret A.WinkerMD, Senior EditorIndividualAuthorPhil B.FontanarosaMD, Senior EditorIndividualAuthor
To the Editor.— I received in the mail
September 10, 1997, a notice from Wal-Mart Pharmacy that they are concerned
that "coronary heart disease remains a leading cause of morbidity and mortality,"
and are "going to do something about it." They then inform me that they can
help ensure that my patients who are "at increased risk" receive—and
stay with—the treatment [I] prescribe." This is especially important
with patients who are receiving Zocor (simvastatin), they say, because Zocor
has been proven to save lives.
Hirsch RL. Merck-Sponsored Simvastatin (Zocor) Compliance Program for Patients Using Wal-Mart Pharmacy: Of Benefit to Whom? JAMA. 1998;279(23):1875–1876. doi:10-1001/pubs.JAMA-ISSN-0098-7484-279-23-jbk0617
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: